Previous Close | 53.17 |
Open | 53.56 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's Range | 52.79 - 54.27 |
52 Week Range | 42.58 - 62.53 |
Volume | |
Avg. Volume | 552,314 |
Market Cap | 4.905B |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | 17.05 |
EPS (TTM) | 3.15 |
Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
Forward Dividend & Yield | 0.88 (1.76%) |
Ex-Dividend Date | May 19, 2022 |
1y Target Est | 63.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for BWXT
OTTAWA, Ontario, June 27, 2022--BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
BWX Technologies Inc (NYSE: BWXT) subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have established a licensing and services agreement. The agreement strengthens their existing partnership for the production of medical isotopes. It enables BWXT Medical to manufacture high purity Actinium-225 (Ac-225) based products for pharmaceutical companies as it continues to build on its medical isotope production operations on the TRIUMF site. Leveraging existing infrastructure
OTTAWA, Ontario, June 13, 2022--BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products